Leila Dadgar

Leila Dadgar

Auto-generated profile, based on publicly available information

Leila Dadgar

Department of Microbiology School of Medicine Iran University of Medical Sciences Tehran Iran iums.ac.ir

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 March 2024 in International Journal Of Clinical Practice
Verified
Journal Article
Open access
PDF file
MAmarzie mahdizade ari
marzie mahdizade ari
LDLeila Dadgar
Leila Dadgar
ZEZahra Elahi
Zahra Elahi
RGRoya Ghanavati
Roya Ghanavati
BTBehrouz Taheri
Behrouz Taheri
The emergence of antibiotic-resistant strains, the decreased effectiveness of conventional therapies, and the side effects have led researchers to seek a safer, more cost-effective, patient-friendly, and effective method that does not develop antibiotic resistance. With progress in synthetic biology and genetic engineering, genetically engineered microorganisms effective in treatment, prophylaxis, drug delivery, and diagnosis have been developed. The present study reviews the types of genetically engineered bacteria and phages, their impacts on diseases, cancer, and metabolic and inflammatory disorders, the biosynthesis of these modified strains, the route of administration, and their effects on the environment. We conclude that genetically engineered microorganisms can be considered promising candidates for adjunctive treatment of diseases and cancers.